Healthcare provider profile · identity verified

Daniel N Duran, M.D.

Family Practice · WEST GROVE, PA · NPI 1467412700

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	419	136
Atorvastatin Calcium	Atorvastatin Calcium	415	119
Levothyroxine Sodium	Levothyroxine Sodium	344	90
Rosuvastatin Calcium	Rosuvastatin Calcium	289	93
Lisinopril	Lisinopril	268	82
Losartan Potassium	Losartan Potassium	228	69
Gabapentin	Gabapentin	213	63
Metoprolol Succinate	Metoprolol Succinate	193	59
Omeprazole	Omeprazole	150	43
Escitalopram Oxalate	Escitalopram Oxalate	146	39
Sertraline Hcl	Sertraline Hcl	145	41
Simvastatin	Simvastatin	136	42
Tamsulosin Hcl	Tamsulosin Hcl	127	43
Metformin Hcl	Metformin Hcl	126	41
Pantoprazole Sodium	Pantoprazole Sodium	124	36
Albuterol Sulfate Hfa	Albuterol Sulfate	114	32
Alprazolam	Alprazolam	109	26
Furosemide	Furosemide	109	43
Glipizide Er	Glipizide	109	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	32
Allopurinol	Allopurinol	107	31
Hydrochlorothiazide	Hydrochlorothiazide	105	32
Ozempic	Semaglutide	100	19
Metformin Hcl Er	Metformin Hcl	96	30
Tramadol Hcl	Tramadol Hcl	83	22
Jardiance	Empagliflozin	79	18
Lorazepam	Lorazepam	76	18
Trazodone Hcl	Trazodone Hcl	73	19
Olmesartan Medoxomil	Olmesartan Medoxomil	70	24
Mounjaro	Tirzepatide	69	13
Fluticasone Propionate	Fluticasone Propionate	68	19
Bupropion Xl	Bupropion Hcl	63	18
Eliquis	Apixaban	63	12
Montelukast Sodium	Montelukast Sodium	62	19
Synthroid	Levothyroxine Sodium	62	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	55	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	19
Carvedilol	Carvedilol	50	18
Zolpidem Tartrate	Zolpidem Tartrate	50	16
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Ezetimibe	Ezetimibe	47	14
Pioglitazone Hcl	Pioglitazone Hcl	47	13
Xarelto	Rivaroxaban	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Methylprednisolone	Methylprednisolone	45	40
Buspirone Hcl	Buspirone Hcl	44	suppressed
Famotidine	Famotidine	43	15
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Meloxicam	Meloxicam	42	19
Clonazepam	Clonazepam	40	suppressed
Atenolol	Atenolol	38	13
Clopidogrel	Clopidogrel Bisulfate	38	13
Mirtazapine	Mirtazapine	37	suppressed
Finasteride	Finasteride	35	11
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Celecoxib	Celecoxib	31	13
Tresiba Flextouch U-200	Insulin Degludec	31	suppressed
Potassium Chloride	Potassium Chloride	30	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	14
Azithromycin	Azithromycin	28	27
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Mometasone Furoate	Mometasone Furoate	25	11
Eszopiclone	Eszopiclone	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Glipizide	Glipizide	22	suppressed
Amoxicillin	Amoxicillin	21	14
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Prednisone	Prednisone	19	13
Zaleplon	Zaleplon	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ramipril	Ramipril	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	13
Ibuprofen	Ibuprofen	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Baclofen	Baclofen	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Testosterone	Testosterone	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valsartan	Valsartan	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error